Search results for "epression"

showing 10 items of 1868 documents

Cognitive dysfunction and depression in Fabry disease: a systematic review.

2013

Background Fabry disease, an X-linked lysosomal storage disorder, leads to multi-organ dysfunction, including cerebrovascular disease and psychological disorders. However, the prevalence and pattern of associated cognitive dysfunction is not well understood. Objectives To investigate whether there is reliable evidence for neuropsychological impairment in patients with Fabry disease and which cognitive domains are affected. To estimate the prevalence of and factors associated with depression in patients with Fabry disease. Method Qualitative systematic review of the literature of studies conducting neuropsychological assessment or measuring the prevalence of depression in adults with Fabry d…

AdultMalePathologymedicine.medical_specialtyNeuropsychological TestsYoung AdultBorderline intellectual functioningPrevalenceGeneticsmedicineHumansNeuropsychological assessmentCognitive skillGenetics (clinical)Depression (differential diagnoses)medicine.diagnostic_testDepressionbusiness.industryNeuropsychologyCognitionFabry disease cognitionMiddle Agedmedicine.diseaseFabry diseaseMeta-analysisFabry DiseaseCognition DisordersbusinessClinical psychology
researchProduct

Everyday Life, Dietary Practices, and Health Conditions of Adult PKU Patients: A Multicenter, Cross-Sectional Study

2020

<b><i>Background:</i></b> Only few data on dietary management of adult phenylketonuria (PKU) patients are published. <b><i>Objectives:</i></b> This study aimed to assess living situation, dietary practices, and health conditions of early-treated adult PKU patients. <b><i>Methods:</i></b> A total of 183 early-treated PKU patients ≥18 years from 8 German metabolic centers received access to an online survey, containing 91 questions on sociodemographic data, dietary habits, and health conditions. <b><i>Results:</i></b> 144/183 patients (66% females) completed the questionnaire. Compared with German …

AdultMalePediatricsmedicine.medical_specialtyAdolescentCross-sectional studyHealth StatusPhenylalanineMedicine (miscellaneous)Living situationProfessional statusYoung AdultQuality of lifePhenylketonuriasSurveys and QuestionnairesActivities of Daily LivingDiet Protein-RestrictedPrevalenceHumansChildbirthMedicineAmino acid intakeAmino AcidsEveryday lifeNutrition and DieteticsDepressionbusiness.industryDietary managementFeeding BehaviorMiddle AgedCross-Sectional StudiesDietary SupplementsQuality of LifePatient ComplianceFemalebusinessAnnals of Nutrition and Metabolism
researchProduct

The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents.

2003

Fabry disease (FD) is a debilitating progressive multisystem X-linked lysosomal storage disorder. It was generally believed that the disease affects only adult males. Through systematic pedigree analysis, we identified 35 paediatric FD patients (age 1 to 21 years, mean 12.6 years) in 25 families. Predominant signs in this cohort were: acroparesthesia, hypohidrosis, and cornea verticillata. Neurological and psychological changes, such as tinnitus, recurrent vertigo, headache, diminished level of activity, fatigue, and depression were often observed. Angiokeratoma and gastrointestinal symptoms were frequent. Some patients also showed cardiac abnormalities. Six children and adolescents (three …

AdultMalePediatricsmedicine.medical_specialtyAdolescentDiseaseRisk AssessmentSeverity of Illness IndexCohort StudiesAge DistributionSeverity of illnessmedicineHumansCornea verticillataGenetic Predisposition to DiseaseSex DistributionChildDepression (differential diagnoses)business.industryIncidenceEnzyme replacement therapymedicine.diseasePrognosisFabry diseaseHealth SurveysAngiokeratomaSurgeryEuropePhenotypeChild PreschoolPediatrics Perinatology and Child HealthFabry DiseaseFemalemedicine.symptombusinessCohort studyEuropean journal of pediatrics
researchProduct

Effects of age on depressive symptomatology and response to antidepressant treatment in patients with major depressive disorder aged 18 to 65 years

2020

Background: There is evidence that symptomatology in patients with major depressive disorder (MDD) changes with age. However, studies comparing depressive symptomatology between different age groups during antidepressant therapy are rare. We compared demographic and clinical characteristics in depressed patients of different age groups at baseline and during treatment. Methods: 889 MDD inpatients were divided into four age groups (18–29, 30–39, 40–49, 50–65 yrs.). Demographic and clinical characteristics including depressive symptomatology (assessed by the Inventory of Depressive Symptoms) were assessed at baseline and weekly during treatment. Results: At baseline, young patients (18–29 yea…

AdultMalePediatricsmedicine.medical_specialtyAdolescentlcsh:RC435-571IrritabilityDepressive symptomatology03 medical and health sciencesYoung Adult0302 clinical medicinelcsh:PsychiatrymedicineHumansIn patientDepression (differential diagnoses)AgedDepressive Disorder Majorbusiness.industryDepressionAge FactorsMiddle Agedmedicine.diseasePersonality disordersAntidepressive AgentsIrritable MoodSelf Concept030227 psychiatrySubstance abusePsychiatry and Mental healthClinical PsychologyTreatment OutcomeAntidepressantMajor depressive disorderFemalemedicine.symptombusiness030217 neurology & neurosurgeryComprehensive Psychiatry
researchProduct

Brief depression among patients in general practice

1994

Depression with substantial psychosocial impairment, but not qualifying as depressive disorder according to the standard diagnostic manuals, is frequent among primary care patients. Recurrent brief depression (RBD) is a diagnostic category intended to identify a major proportion of this group of patients. The WHO study on "Psychological Problems in Primary Health Care" was used as a vehicle to estimate the proportion of patients with this diagnosis and to evaluate the validity of this diagnosis as well as of alternative concepts of brief depression with multiple episodes. This study applies a two-stage sampling scheme; 300 patients also underwent an additional interview tailored for variant…

AdultMalePediatricsmedicine.medical_specialtyBipolar DisorderAdolescentPersonality InventoryPsychometricsPrevalencePrimary health careComorbidityPrimary careRecurrent brief depressionRecurrenceGermanymedicineHumansPharmacology (medical)Sex RatioBiological PsychiatryDepression (differential diagnoses)AgedPsychiatric Status Rating ScalesDepressive DisorderSampling schemePrimary Health Carebusiness.industryIncidenceGeneral MedicineMiddle Agedmedicine.diseasePsychiatry and Mental healthCross-Sectional StudiesGeneral practiceFemalebusinessPsychosocialEuropean Archives of Psychiatry and Clinical Neuroscience
researchProduct

Remission in schizophrenia — What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remissio…

2019

Despite being recommended for use in clinical trials, the consensus remission criteria were found to leave patients with persisting symptoms, relevant areas of functional impairment and a decreased sense of wellbeing. Therefore, to evaluate the appropriateness of the schizophrenia consensus criteria, a definition of remission based on the Clinical Global Impression Scale (CGI) was developed and remitter subgroups were compared.239 patients with a schizophrenia spectrum disorder were evaluated regarding their remission status after inpatient treatment. Remission in schizophrenia was defined according to the symptom-severity component of the consensus criteria by Andreasen et al. and a CGI ba…

AdultMalePediatricsmedicine.medical_specialtyConsensusMedizinConsensus criteriaSeverity of Illness IndexAsymptomaticYoung Adult03 medical and health sciences0302 clinical medicineRemission criteriaOutcome Assessment Health Caremental disordersmedicineHumansBiological PsychiatryDepression (differential diagnoses)Depressive Disorder Majorbusiness.industryRemission InductionMiddle Agedmedicine.disease030227 psychiatry3. Good healthClinical trialPsychiatry and Mental healthSchizophreniaSchizophreniaClinical Global ImpressionFemalemedicine.symptombusiness030217 neurology & neurosurgeryFollow-Up StudiesSchizophrenia spectrum
researchProduct

Agreement in Asthmatics' Perception of Dyspnea During Acute and Chronic Obstruction

2005

Objective Three types of asthmatic patients can be identified during periods of clinical stability: “poor perceivers,” “normal perceivers,” and “over perceivers.” When asthmatics undergo bronchial challenge in the laboratory, the same distinctions in type of perception can be observed. The aim of the present study was to determine the level of agreement between the 2 situations. Patients and methods A total of 93 patients with persistent moderate asthma (36 men and 57 women; mean age 40 years) were studied. We asked them to assess their dyspnea on a modified Borg scale when stable and after each histamine dose in a bronchial provocation test. When a patient's Borg scale assessment in stable…

AdultMalePercentilemedicine.medical_specialtyAdolescentBronchoconstrictionmedia_common.quotation_subjectModerate asthmaAnxietyAudiologyAirflow obstructionSeverity of Illness IndexPulmonary Disease Chronic ObstructiveSurveys and QuestionnairesPerceptionHumansMedicineAgedmedia_commonDepressionbusiness.industryMean ageGeneral MedicineMiddle AgedAsthmaDyspneaBronchial provocationSpirometryAcute DiseasePhysical therapyFemaleBronchoconstrictionmedicine.symptombusinessAttitude to HealthBronchial challengeArchivos de Bronconeumología ((English Edition))
researchProduct

[Spanish asthma patients' beliefs about health and medicines: validation of 2 questionnaires].

2008

Abstract Objective We translated 2 health beliefs questionnaires–an instrument based on the health belief model (HBM) containing 19 items in 6 domains and the Beliefs About Medicines Questionnaire (BMQ) containing 18 items divided into a general and a specific section–and then administered and validated them in a group of Spanish patients with asthma. Patients and Methods In 2 clinical visits data were collected on 126 patients with stable asthma of different levels of severity. At the first visit, the patients underwent spirometry and were asked questions about sociodemographic factors and clinical history. At the second visit, they completed the State-Trait Anxiety Inventory, the Beck Dep…

AdultMalePersonality InventoryCultureAnxietyTrustSeverity of Illness IndexCronbach's alphaSurveys and QuestionnairesSeverity of illnessmedicineContent validityHealth belief modelHumansAnti-Asthmatic AgentsProspective StudiesAsthmaPhysician-Patient Relationsbusiness.industryDepressionBeck Depression InventoryGeneral MedicineMiddle Agedmedicine.diseaseAsthmaSocioeconomic FactorsSpainSpirometryAnxietyFemalemedicine.symptomPersonality Assessment InventorybusinessAttitude to HealthClinical psychologyArchivos de bronconeumologia
researchProduct

A Confirmatory Study on the Mechanisms Behind Reduced P300 Waves in Depression

2003

A single-trial analysis of event-related potentials (P300) of 21 depressives was performed in comparison with matched controls. The purpose was to confirm previous results revealing an overall reduction of the single-trial P300 amplitude in depression despite fewer elicited single-trial P300 waves in schizophrenics. The result of the present study is in line with our previous investigation implicating a general reduced P300 amplitude on single trials of depressive patients. Therefore, it appears possible to differentiate depressives and schizophrenics by measuring event-related potentials and applying a single-trial analysis of them.

AdultMalePharmacologyAnalysis of VarianceDepressive Disorder Majormedicine.medical_specialtyCase-control studyMiddle AgedAudiologyP300 amplitudeEvent-Related Potentials P300Developmental psychologyPsychiatry and Mental healthEvent-related potentialLinear ModelsmedicineHumansFemalePsychologyDepression (differential diagnoses)Neuropsychopharmacology
researchProduct

Psychological distress associated with the COVID-19 lockdown: A two-wave network analysis

2021

Abstract Background Although preliminary research has evidenced negative psychological consequences of the COVID-19 pandemic among the general population, little research has been carried out examining the interplay among the broader dimensions and correlates of individual distress. Via network analysis, the current study investigated the pathways that underlie some components of psychological distress and their changes over time (during and post COVID-19-related lockdown). Methods 1,129 adult participants (79.1% women) completed a two-wave online survey during and after the lockdown, and reported on variables such as depression, anxiety, stress, fear of COVID, intolerance of uncertainty, e…

AdultMalePopulationContext (language use)AnxietyPsychological DistressIntolerance of uncertainty [Fear of COVID]03 medical and health sciencesSocial support0302 clinical medicineSettore M-PSI/08 - Psicologia ClinicamedicineCOVID-19 Depression Emotion regulation Fear of COVID: Intolerance of uncertainty Network analysisHumanseducationPandemicsDepression (differential diagnoses)education.field_of_studyCOVID-19; Depression; Emotion regulation; Fear of COVID: Intolerance of uncertainty; Network analysisDepression Emotion regulation Fear of COVID Intolerance of uncertainty Network analysisSARS-CoV-2DepressionEmotion regulationCOVID-19Fear of COVID: Intolerance of uncertaintyMental health030227 psychiatryDistressPsychiatry and Mental healthClinical PsychologyCommunicable Disease ControlAnxietyFemaleNetwork analysismedicine.symptomPsychologyPsychosocial030217 neurology & neurosurgeryStress PsychologicalClinical psychologyResearch Paper
researchProduct